Evidence map›Paper›PMID 34982247›Full record

ArticleCurrent microbiology2022

A Three-Dimensional Lung Cell Model to Leptospira Virulence Investigations.

Camila L Campos, Luciana R Gomes, Ambart E Covarrubias, Ellen E Kato, Gisele G Souza, Silvio A Vasconcellos, Marcos B Heinemann, Elizabeth A L Martins, Paulo L Ho, Renata M A Da Costa and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Camila L CamposLaboratório de Bacteriologia, Instituto Butantan, São Paulo, Brazil.
Luciana R GomesLaboratório de Ciclo Celular-Center for Research on Toxins, Immune-Response and Cell Signaling (CeTICS), Instituto Butantan, São Paulo, Brazil.
Ambart E CovarrubiasFacultad de Ciencias de la Salud, Escuela de Tecnología Médica, Universidad San Sebastian, Concepción, Chile.
Ellen E KatoLaboratorio de Fisiopatologia, Instituto Butantan, São Paulo, Brazil.
Gisele G SouzaLaboratório de Zoonoses Bacterianas, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil.
Silvio A VasconcellosLaboratório de Zoonoses Bacterianas, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil.
Marcos B HeinemannLaboratório de Zoonoses Bacterianas, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil.
Elizabeth A L MartinsLaboratório de Biológicos Recombinantes, Instituto Butantan, São Paulo, Brazil.
Paulo L HoDivisão BioIndustrial, Instituto Butantan, São Paulo, Brazil.
Renata M A Da CostaLaboratório de Bacteriologia, Instituto Butantan, São Paulo, Brazil.
Josefa B Da SilvaLaboratório de Bacteriologia, Instituto Butantan, São Paulo, Brazil. josefa.silva@butantan.gov.br.ORCID http://orcid.org/0000-0003-3884-7111
Instituto Butantan · BRUniversidade de São Paulo · BRSan Sebastián University · CL

Funding

fundação de amparo à pesquisa do estado de são paulo 2013/16451-1fundação de amparo à pesquisa do estado de são paulo 2017/20903-6
6 · The paper itself

Abstract

Leptospirosis is a worldwide zoonosis and a serious public health threat in tropical and subtropical areas. The etiologic agents of leptospirosis are pathogenic spirochetes from the genus Leptospira. In severe cases, patients develop a pulmonary hemorrhage that is associated with high fatality rates. Several animal models were established for leptospirosis studies, such as rodents, dogs, and monkeys. Although useful to study the relationship among Leptospira and its hosts, the animal models still exhibit economic and ethical limitation reasons and do not fully represent the human infection. As an attempt to bridge the gap between animal studies and clinical information from patients, we established a three-dimensional (3-D) human lung cell culture for Leptospira infection. We show that Leptospira is able to efficiently infect the cell lung spheroids and also to infiltrate in deeper areas of the cell aggregates. The ability to infect the 3-D lung cell aggregates was time-dependent. The 3-D spheroids infection occurred up to 120 h in studies with two serovars, Canicola and Copenhageni. We standardized the number of bacteria in the initial inoculum for infection of the spheroids and we also propose two alternative culture media conditions. This new approach was validated by assessing the expression of three genes of Leptospira related to virulence and motility. The transcripts of these genes increased in both culture conditions, however, in higher rates and earlier times in the 3-D culture. We also assessed the production of chemokines by the 3-D spheroids before and after Leptospira infection, confirming induction of two of them, mainly in the 3-D spheroids. Chemokine CCL2 was expressed only in the 3-D cell culture. Increasing of this chemokine was observed previously in infected animal models. This new approach provides an opportunity to study the interaction of Leptospira with the human lung epithelium in vitro.

Indexed as

Cell Culture Techniques, Three DimensionalLeptospiraLeptospirosisAnimalsHumansLungVirulence

Identifiers

PMID34982247
OpenAlexW4205311506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.